Rare diseases
Investigational molecules
Locations
777 Old Saw Mill River Road, 10591-6717, United States
Regeneron Pharmaceuticals Inc. funds extensive research in non-small cell lung cancer, including advanced, resectable, and biomarker-defined disease, alongside studies in melanoma, cutaneous squamous cell carcinoma, basal cell carcinoma, ovarian cancer, and other advanced solid tumors. Its oncology portfolio also includes multiple programs in multiple myeloma, follicular lymphoma, marginal zone lymphoma, diffuse large B-cell lymphoma, mantle cell lymphoma, and high-risk monoclonal gammopathy of undetermined significance.
Additional oncology interests extend to head and neck squamous cell carcinoma, endometrial cancer, renal-cell carcinoma, primary peritoneal cancer, and perioperative treatment strategies for surgically managed malignancies.
Regeneron Pharmaceuticals Inc. runs clinical trials in conditions such as Embolism, Non-small cell lung cancer, Malignant melanoma, Plasma cell myeloma refractory, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Phase 3 study comparing linvoseltamab and daratumumab in high‑risk smoldering multiple myeloma patients
FranceStudy of REGN7508 versus apixaban for treating and preventing cancer-associated blood clots in adults with solid or blood cancers
BulgariaA study of the safety and effectiveness of REGN17372 and linvoseltamab in adults with relapsed or refractory multiple myeloma
GreeceA study to evaluate the effectiveness and safety of REGN13335 in adults with pulmonary arterial hypertension
BelgiumStudy of ubamatamab alone or with cemiplimab for adults with ovarian, fallopian tube, peritoneal, or endometrial cancer that has come back
BelgiumA Study of Linvoseltamab in Adult Patients with High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma
BelgiumA study comparing odronextamab combined with chemotherapy versus rituximab combined with chemotherapy in adults with previously untreated follicular lymphoma
AustriaA Study of Mibavademab for Weight Loss in Children, Adolescents and Adults with Obesity Caused by LEP Gene Mutations
GermanyComparison of REGN7508 versus apixaban and enoxaparin to prevent blood clots in adults after knee replacement surgery
BulgariaStudy of Pozelimab and Cemdisiran for Adults with Geographic Atrophy from Age-Related Macular Degeneration
AustriaStudy of Linvoseltamab in Adults with Relapsed or Refractory Multiple Myeloma
BelgiumStudy of Cemiplimab, Carboplatin, and Paclitaxel for Adults with Operable Non-Small Cell Lung Cancer
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
